I-Novel coronavirus pneumonia idonsela ukunaka e-European Union

Ukukhathazeka kuphakanyiswe e-Europe mayelana nokusebenza ngempumelelo kokwelashwa kwe-COVID-19

Ukushicilelwa kwaleli phepha kwadonsa ukunaka okukhulu eYurophu.

Ucwaningo lusebenzisa izindlela zokucwaninga ezizokwenzeka, ezingaphuphutheki, ezilawulwa ngokungahleliwe, ezimaphakathi amaningi ukuze kuhlolwe ukuthi ukungezwa kwe-Lianhua Qingwen Capsules ngesisekelo sokwelashwa okuvamile kungenza iziguli zithole ukusebenza kahle komtholampilo.Idatha yokuhlolwa yalolu cwaningo yahlaziywa inkampani yangaphandle ephrofeshinali.Imiphumela yabonisa ukuthi iqembu lokwelapha i-Lianhua Qingwen lenze ngcono kakhulu izinga lokunyamalala kwezimpawu zomtholampilo eziyinhloko (umkhuhlane, ukukhathala, ukukhwehlela) ngemva kwezinsuku ezingu-14 zokwelashwa, lafinyelela ku-57.7% wokwelashwa izinsuku ezingu-7 kanye nama-80.3 izinsuku ezingu-10 zokwelashwa.%, 91.5% ngemva kwezinsuku ezingu-14 zokwelashwa.Ubude besikhathi sezimpawu zomuntu ngamunye zemfiva, ukukhathala, nokukhwehlela nakho kwafinyezwa kakhulu.Ngesikhathi esifanayo, iqembu lokwelapha i-Lianhua Qingwen lazithuthukisa kakhulu izici zokuthwebula ze-CT yamaphaphu.Mayelana nenani elibi le-nucleic acid kanye nesikhathi senyumoniya entsha ye-coronary, izinga elibi le-nucleic acid leqembu lokwelapha ngemuva kwezinsuku eziyi-14 lokwelashwa nge-Lianhua Qingwen Capsule lalingu-76.8%, futhi isikhathi esibi kwakuyizinsuku eziyi-11, okubonisa ukuthambekela okuthile uma kuqhathaniswa ne iqembu lokulawula.Uma kuqhathaniswa neqembu lokwelapha elivamile, ukuncishiswa kwengxenye yokuguqulwa okunzima kwehliswe ngo-50% (ingxenye yoshintsho olunzima eqenjini lokwelapha i-Lianhua Qingwen yayingu-2.1%, kanye neqembu lokwelapha elivamile 4.2%).Lokhu kukhombisa ukuthi ukusetshenziswa kweLianhua Qingwen izinsuku eziyi-14 ngesisekelo sokwelashwa okuvamile kungakhuphula kakhulu izinga lokunyamalala kwezimpawu zomtholampilo ezifana nomkhuhlane, ukukhathala, nokukhwehlela kwenyumoniya entsha yenhliziyo, kuthuthukise kakhulu izici zokucabanga kwamaphaphu, futhi kufinyeze isikhathi izimpawu.Lokhu kubonisa ukuthi i-Lianhua Qingwen Capsules ingathuthukisa izimpawu zomtholampilo futhi ithuthukise imiphumela yomtholampilo lapho isetshenziswa ekwelapheni iziguli ezinenyumoniya entsha ye-coronary.Leli phepha liphinde laveza ukuthi imiphumela yocwaningo lomtholampilo ayiqinisekisanga nje kuphela ukuthi i-Lianhua Qingwen Capsules ingathuthukisa izimpawu zomtholampilo kanye nemiphumela yomtholampilo yesiguli.